🕵️ Anebulo Pharmaceuticals, Inc. ($ANEB)
SEC insider & ownership activity, last 12 months · CIK 1815974 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Feb 5, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Aron R. English | 51.1% | 13D | Feb 24, 2025 | filing ↗ | |
| Aron R. English | 51.1% | 13D | Dec 23, 2024 | filing ↗ | |
| 22 NW Fund, LP | 40.1% | 13D | Feb 24, 2025 | filing ↗ | |
| 22 NW Fund, LP | 40.1% | 13D | Dec 23, 2024 | filing ↗ | |
| Pharma Investors, LLC | 11.3% | 13D | Feb 24, 2025 | filing ↗ | |
| Pharma Investors, LLC | 11.3% | 13D | Dec 23, 2024 | filing ↗ | |
| Nantahala Capital Management, LLC | 8.5% | 13G | Feb 13, 2026 | filing ↗ | |
| Wilmot B. Harkey | 8.5% | 13G | Feb 13, 2026 | filing ↗ | |
| Daniel Mack | 8.5% | 13G | Feb 13, 2026 | filing ↗ | |
| Mangrove Partners IM, LLC | 6.2% | 13G | Mar 17, 2025 | filing ↗ | |
| Nathaniel August | 6.2% | 13G | Mar 17, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Feb 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing ↗ |
| Delisting notice (3.01) | Feb 5, 2026 | filing ↗ |
| Other events (8.01) | Feb 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 5, 2026 | filing ↗ |
| Other events (8.01) | Jan 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 29, 2026 | filing ↗ |
| Other events (8.01) | Jan 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 26, 2026 | filing ↗ |
| Other events (8.01) | Dec 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 22, 2025 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Earnings (2.02) | Sep 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 29, 2025 | filing ↗ |
| Other events (8.01) | Sep 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 12, 2025 | filing ↗ |